# Role Of Sensitivity to neuroEndocrine Systems in Social Decisions

> **NCT06018727** · PHASE4 · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DRUG:** Hydrocortisone
- **DIETARY_SUPPLEMENT:** Yohimbine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06018727
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-07
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Changed study design and it is no longer a clinical trial.
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06018727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06018727, "Role Of Sensitivity to neuroEndocrine Systems in Social Decisions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06018727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
